Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma

This publication has 117 references indexed in Scilit:

• Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa
  PLOS ONE, 2013
• Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma
  Journal of Biomedical Science, 2012
• Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
  BMC Cancer, 2012
• Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells
  PLOS ONE, 2011
• Potentiating Cancer Immunotherapy Using an Oncolytic Virus
  Molecular Therapy, 2010
• Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
  Cell, 2009
• Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
  Human Gene Therapy, 2008
• Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
  Proceedings of the National Academy of Sciences, 2008
• Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
• Adeno-Associated Virus Type 12 (AAV12): a Novel AAV Serotype with Sialic Acid- and Heparan Sulfate Proteoglycan-Independent Transduction Activity
  Journal of Virology, 2008